# Study of Satraplatin With Capecitabine to Treat Advanced Solid Malignancies

> **NCT00329329** · PHASE1 · TERMINATED · sponsor: **Agennix** · enrollment: 24 (actual)

## Conditions studied

- Malignancies

## Interventions

- **DRUG:** satraplatin and capecitabine

## Key facts

- **NCT ID:** NCT00329329
- **Lead sponsor:** Agennix
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-05
- **Primary completion:** 2009-01
- **Final completion:** 2009-02
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** Sponsor decided to discontinue study drug development
- **Last updated:** 2012-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00329329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00329329, "Study of Satraplatin With Capecitabine to Treat Advanced Solid Malignancies". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00329329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*